Elba Cruz – Site Director, Haleon, Puerto Rico
Elba Cruz, Site Director at Haleon Puerto Rico, shares how the Guayama facility has become a critical manufacturing hub for Haleon’s global operations, driven by a skilled local workforce, robust…
The CDI mission is to empower research and development in proteomics with proprietary technologies, making possible — today — the protein discoveries of tomorrow. CDI’s HuProt protein microarrays and related services make it possible to perform rapid and efficient analyses of thousands of protein interactions using minimal amounts of valuable research or clinical samples.
The company’s microarray-powered monoclonal antibodies (MAbs] and MAb-related services provide unprecedented levels of specificity. Our system of antibody production is part of the NIH Protein Capture Reagents program and is currently working to produce truly mono-specific antibodies to human transcription factors.
CDI has patents in process for technologies to increase high through put analysis of protein-protein interactions as well as high throughput development of antibodies and identification of biomarkers
At CDI we believe that partnering with both companies and academic scientists is the path to mutual success. So please contact our business development professionals for possible collaborations or partnerships.
The Company has locations in Baltimore, Maryland and in Mayaguez, Puerto Rico.
Contact details
Guanajibo Research and Innovation Park
4005 Street B, Road 114 Km 1.3
Mayaguez, PR 00682
USA
T: 787-806-4010
F: 787-806-4006
www.cdi-lab.com
Elba Cruz, Site Director at Haleon Puerto Rico, shares how the Guayama facility has become a critical manufacturing hub for Haleon’s global operations, driven by a skilled local workforce, robust…
Jesus Manuel Laboy, President at VIBRA Inc., a company that provides predictive maintenance and reliability engineering services for industries across the Americas, shares the company’s evolution from its origins in…
At a time when the pharmaceutical industry faces increasing complexity and scrutiny, Javier Deida, Country Lead of Pfizer Puerto Rico, is spearheading a quietly transformative effort on the island. With…
From its origins as a modest logistics firm in 1982, GMD Airline Services has grown into a critical enabler of Puerto Rico’s pharmaceutical and medical device supply chain. At the…
With a uniquely positioned healthcare system and early access to innovation, Puerto Rico has become a proving ground for Organon’s regional ambitions in Latin America and the Caribbean. In a…
Mary Carmen Zapata brings over 30 years of experience at PREPA into her historic role as the organisation’s first female CEO. Since taking office in January 2025, her top priority has…
Already a solid hub for biopharma manufacturing and logistics, Puerto Rico is moving to sharpen its position in the evolving US reshoring landscape and attract new investment. Under the banner…
Felix and Manuel de la Cruz of M&N Electronics discuss the company’s evolution over the years and its commitment to becoming the leading provider of industrial equipment in Puerto Rico.…
Omar Muñiz, President of Share Tech, discusses the company’s remarkable growth over the past two decades and its strategic diversification beyond the healthcare and life sciences sectors. He highlights the…
Yolanda Lassalle, founder and CEO of LaSalle Group, shares how she built a global consulting firm rooted in operational excellence, people development, and innovation. Speaking from Puerto Rico, Lassalle reflects…
As regulatory expectations grow more complex and regional fragmentation persists, navigating Latin America’s life sciences landscape requires more than technical know-how; it demands agility, strategic insight, and trusted local partnerships.…
Carlos Ceinos, President & Co-Founder of Principia, leads a Puerto Rico-based consulting firm focused on automation, MES, project management, and validation for the biopharmaceutical industry. Since 2019, the company has…
See our Cookie Privacy Policy Here
